Global Oncology Cancer Drugs Market ( Cancer Types,Geography ) 2013-2020

1
Global Oncology/Cancer Drugs Market (Therapeutic
Modalities, Cancer Types and Geography) www.bigm
arketresearch.com
2
Acquired (Autoimmune) Hemolytic Anemia
Report Description
Biological drugs based on monoclonal antibodies
(mAbs) have emerged as a preferred option for
treating various cancer types, especially for
blood cancer (leukemia). Rising incidence of
various cancer conditions, growing popularity of
advance therapies (biological and targeted drug
therapies), patents expiration of leading drugs
along with commercialization of biosimilars are
the few factors driving the growth of global
oncology drugs market. However, high cost
involved in new drug development coupled with
threat of failure and adverse effects associated
with cancer drugs therapies would restrain the
growth of the market. Commercialization of
advanced therapeutics such as targeted and
immunotherapies would reduce the negative
influence of restraints and fuel the market
growth. Read complete report here _at_
http//www.bigmarketresearch.com/oncology-cancer-
drugs-market
3
Acquired (Autoimmune) Hemolytic Anemia
Report Description
The global oncology drugs market is expected to
reach at 111.9 billion by 2020. Patent
expiration of key cancer drugs such as Herceptin,
Erbitux, Rituxan and Avastin, is expected to
boost the growth of cancer biosimilars market by
2020. Going further, the biological therapies are
expected to dominate the market by 2020, due to
their high efficacy, target specific action and
less toxicity. Blood cancer drugs market was the
largest revenue generating segment in 2013 owing
to the high cost of drugs (immunotherapies) used
for the treatment of blood cancer. Download
Sample Report _at_ http//www.bigmarketresearch.com/
request-sample/22695
4
Acquired (Autoimmune) Hemolytic Anemia
Report Description
Geographically, North America, dominates the
market followed by Europe. North America
accounted for about 38 share in the overall
oncology drugs market in 2013 owing to the heavy
investments by multinational companies in
research and development of cancer drugs,
particularly immune therapeutics, favorable
reimbursement policies, and high adoption rate of
immunotherapies. On the other hand, Asia-Pacific
market would grow at the promising CAGR of 8.7
during the forecast period. Such high growth rate
is majorly due to increasing awareness towards
advanced therapies namely immunotherapies and
increase in per capita healthcare spending. Key
companies profiled in the report are Roche
diagnostics, Novartis AG, Celgene Corporation,
AstraZeneca, Johnson Johnson, Merck Co., Eli
Lilly Co. and GlaxoSmithKline. Companies
operating in the cancer drugs market focus on
several strategies such as collaboration,
approval and acquisition. Get enquire about
report here _at_ http//www.bigmarketresearch.com/re
port-enquiry/22695
5
Acquired (Autoimmune) Hemolytic Anemia
Table Of Contents
CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE
SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4
GLOBAL ONCOLOGY/CANCER DRUGS MARKET BY
THERAPEUTIC MODALITIES CHAPTER 5 GLOBAL
ONCOLOGY/CANCER DRUGS MARKET BY CANCER
TYPES CHAPTER 6 GLOBAL ONCOLOGY/CANCER DRUGS
MARKET BY GEOGRAPHY CHAPTER 7 COMPANY
PROFILES Read complete TOC _at_ http//www.bigmarke
tresearch.com/oncology-cancer-drugs-market
6
Acquired (Autoimmune) Hemolytic Anemia
Report Description
KEY BENEFITS The report provides the
quantitative analysis of the current market and
estimations through 2013-2020 that assists in
identifying the prevailing market opportunities
to capitalize on The report helps in
understanding the strategies adopted by various
companies for gaining market share in the cancer
drugs market The report provides comprehensive
analysis of factors that drive and restrict the
growth of the cancer drugs market Market
conditions of cancer drugs market across all
geographic regions are comprehensively
analyzed Competitive intelligence (of leading
manufacturers) helps in understanding the
competitive scenario across the geographies SWOT
analysis of the key market players is provided to
illustrate the business strategies adopted by the
companies
7
Acquired (Autoimmune) Hemolytic Anemia
Report Description

• MARKET SEGMENTATION
• The cancer drugs market is segmented by the
  therapeutic modalities, cancer types and
  geography.
• MARKET BY THERAPEUTIC MODALITIES
• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others
• MARKET BY CANCER TYPES
• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer

8
Acquired (Autoimmune) Hemolytic Anemia
Report Description

• MARKET BY GEOGRAPHY
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Others
• Asia-Pacific
• India
• China
• Japan
• Australia
• Others
• LAMEA
• GCC (Gulf Corporation Council)

9
Acquired (Autoimmune) Hemolytic Anemia
Report Description

• MARKET BY GEOGRAPHY
• North America
• Europe
• Asia-Pacific
• LAMEA
• Request for Discount _at_
• http//www.bigmarketresearch.com/purchase-enquiry/
  22695

10
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/oncology-cancer-d
rugs-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com